recent
studi
establish
new
regulatori
axi
reninangiotensin
system
ra
axi
angiotensin
ang
final
produc
ang
ang
ii
catalyt
activ
angiotensinconvert
enzym
ang
show
action
differ
receptor
stimul
vasodilat
natriuresi
antiprolifer
increas
bradykininno
nitric
oxid
system
catalyt
effici
approxim
higher
ang
ii
substrat
ang
axi
possibl
act
counterregulatori
system
aceang
iiat
receptor
axi
signal
pathway
axi
yet
total
clearli
understood
howev
recent
report
suggest
ma
oncogen
act
receptor
ang
intracellular
signal
ma
clear
yet
sever
factor
akt
phosphoryl
protein
kinas
c
activ
mitogenactiv
protein
map
kinas
inhibit
seem
involv
signal
pathway
investig
need
clarifi
regul
mechan
action
ang
howev
second
axi
ang
ra
import
target
therapi
cardiovascular
metabol
disord
reninangiotensin
system
ra
critic
role
cardiovascular
system
recent
studi
ra
found
variou
compon
propos
new
axe
signal
pathway
classic
system
angiotensin
ang
ii
produc
ang
angiotensinconvert
enzym
ace
strong
bioactiv
substanc
ang
ii
bind
two
major
type
receptor
name
ang
ii
type
ang
ii
type
receptor
signal
pathway
well
studi
includ
identif
new
signalingrel
molecul
receptorassoci
protein
atrap
receptorinteract
protein
atip
cardiovascular
diseas
receptor
stimul
seem
antagon
signal
associ
receptor
stimul
bind
affin
ang
ii
receptor
differ
receptor
consid
receptor
stimul
contribut
benefici
action
receptor
blocker
arb
context
receptor
agonist
compound
newli
develop
expect
function
use
agent
patholog
disord
futur
recent
new
axi
ra
establish
axi
ang
final
convert
ang
catalyt
activ
mechan
action
ang
still
investig
mani
research
group
santo
et
al
report
ma
oncogen
receptor
ang
increas
number
report
role
ang
ma
cardiovascular
system
review
outlin
role
function
ang
pathway
discuss
comparison
classic
aceang
iiat
receptor
axi
ang
ii
wellknown
bioactiv
substanc
involv
regul
blood
pressur
ang
ii
involv
exagger
cardiovascular
diseas
recent
studi
indic
ang
ii
also
involv
onset
diabet
metabol
disord
classic
ra
ang
ii
produc
ang
action
ace
classic
axi
call
aceangiiat
receptor
axi
find
close
relat
develop
ra
inhibitor
ace
inhibitor
arb
major
receptor
subtyp
ang
ii
receptor
receptor
clone
find
contribut
develop
arb
acceler
basic
clinic
research
distribut
receptor
cover
organ
wherea
receptor
express
observ
organ
birth
upregul
patholog
state
receptor
stimul
mediat
classic
major
action
ang
ii
larg
clinic
trial
basic
research
establish
concept
cardiovascular
continuum
propos
dzau
et
al
stimul
fact
known
exert
hypertens
stroke
cardiovascular
event
renal
diseas
figur
also
report
blockad
receptor
promot
longev
recent
year
effort
carri
produc
inhibitor
ra
first
trial
produc
renin
inhibitor
succeed
clinic
use
chemic
technic
difficulti
howev
effort
produc
ace
inhibitor
success
trigger
develop
new
ra
inhibitor
ace
inhibitor
advers
effect
cough
addit
chronic
administr
ace
inhibitor
show
escap
phenomenon
inhibitori
action
ace
inhibitor
strongli
attenu
solv
problem
arb
develop
second
ra
inhibitor
action
ang
ii
mediat
receptor
nonpeptid
arb
avail
wide
use
treatment
hypertens
cardiovascular
renal
diseas
ang
ii
act
mainli
receptor
use
variou
signal
mechan
exampl
receptor
stimul
increas
influx
extracellular
ca
mobil
intracellular
ca
increas
intracellular
ca
level
activ
acut
respons
vascular
smoothmuscl
contract
also
activ
variou
kinas
includ
mitogenactiv
protein
map
kinas
pathway
induc
cellprolifer
signal
receptor
stimul
seem
activ
egf
receptor
plasma
membran
therefor
part
action
caus
receptor
stimul
similar
caus
ca
mobil
hormon
egf
famili
contrast
signal
mediat
receptor
stimul
transfer
mainli
phosphatas
therefor
action
receptor
stimul
consid
antagon
receptormedi
signal
fact
antagon
action
counterregul
receptor
stimul
report
previous
role
ang
ma
axisa
new
ra
pathway
possibl
effect
vasodil
mediat
ang
report
howev
mechan
lead
ang
product
receptor
unclear
result
delay
ang
base
research
recent
report
show
ang
produc
activ
report
highli
express
heart
kidney
testi
membraneassoci
hydrolas
hydrolyz
ang
ang
ang
ii
ang
figur
ang
convert
ang
ace
peptidas
facilit
ang
product
two
separ
pathway
ang
lose
one
amino
acid
ang
ii
might
possibl
ang
degrad
product
ang
ii
one
inactiv
mechan
ang
ii
howev
recent
studi
indic
ang
activ
role
ra
ang
caus
vasodil
antagon
receptor
stimulationmedi
vasoconstrict
effect
seem
mediat
bradykininno
nitric
oxid
pathway
accordingli
result
suggest
ang
antagon
pressor
effect
receptor
stimul
suggest
may
act
kind
receptor
antagonist
therebi
result
bloodpressurelow
effect
organprotect
effect
reduct
cardiac
hypertrophi
fibrosi
renal
damag
figur
report
lack
acceler
pressureoverloadinduc
cardiac
dysfunct
hand
ang
agonist
figur
role
receptor
stimul
hypertens
organ
damag
nitric
oxid
ckd
chronic
kidney
diseas
product
angiotensin
angiotensinconvert
enzym
iwai
horiuchi
cardioprotect
diabet
rat
addit
ang
potenti
bradykinin
either
receptordepend
mechan
inhibit
ace
recent
studi
also
shown
ang
similar
ace
inhibitor
potenti
effect
bradykinin
inhibit
desensit
receptor
discov
catalyt
effici
approxim
higher
ang
ii
substrat
ang
suggest
second
arm
system
act
counterregul
first
arm
previou
report
suggest
olmesartan
arb
increas
plasma
concentr
ang
cardiac
level
anoth
arb
losartan
also
induc
similar
chang
howev
dose
higher
olmesartan
suggest
effect
arb
class
effect
detail
analysi
could
show
regul
ma
could
contribut
toward
new
drug
discoveri
regul
ra
recent
studi
function
suggest
import
role
sever
lung
failur
acut
respiratori
distress
syndrom
ard
acut
lung
injuri
moreov
shown
sever
acut
respiratori
syndrom
sar
corona
viru
util
essenti
receptor
cell
fusion
vivo
infect
suggest
contribut
sar
pathogenesi
result
indic
activ
import
role
cardiovascular
diseas
also
damag
dysfunct
organ
expect
studi
function
contribut
toward
new
therapi
organ
damag
target
enzym
recent
report
suggest
ma
oncogen
act
receptor
ang
ma
class
gproteincoupl
receptor
contain
aminoacid
residu
express
ma
abundantli
express
brain
testi
low
level
ma
express
also
observ
tissu
heart
kidney
lung
liver
spleen
tongu
skelet
muscl
studi
use
balanc
ace
activ
affect
cardiovascular
disord
ace
angiotensinconvert
enzym
ang
angiotensin
angiotensinii
receptor
angiotensinii
receptor
masdefici
mice
show
impair
cardiac
function
mice
recent
studi
suggest
rac
cjun
nh
termin
kinas
jnk
map
kinas
activ
phospholipas
c
might
involv
masmedi
signal
one
major
pathway
ma
signal
cardiovascular
system
phosphoryl
akt
moreov
cardiomyocyt
inhibit
map
kinas
activ
ang
block
antisens
oligonucleotid
ma
detail
research
work
show
ma
function
clearli
recent
year
sever
class
ra
inhibitor
develop
inhibitor
effect
hypertens
patient
hypertensionassoci
patholog
disord
ace
inhibitor
arb
renin
inhibitor
alreadi
avail
hypertens
patient
moreov
receptor
agonist
compound
could
use
futur
previou
studi
detail
mechan
regul
ma
axi
clearli
state
howev
clarifi
pathway
act
counterregul
system
aceang
iiat
receptor
pathway
therefor
suggest
ma
axi
could
becom
new
target
therapi
circulatori
disord
adult
diseas
includ
metabol
syndrom
total
effect
ra
seem
stand
balanc
ace
activ
figur
respect
could
consid
classic
aceang
iiat
receptor
axi
play
devil
ma
axi
play
angel
fruit
age
ra
blood
pressur
lower
organ
protect
author
declar
conflict
interest
